Neurologic complications of anthrax: A review of the literature

Archives of Neurology

Volumn 60, Issue 4, 2003, Pages 483-488

  Meyer, Michael Andrew ^a  

^a DENT NEUROLOGIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; BACILLUS ANTHRACIS; BACILLUS CEREUS; BIOLOGICAL WARFARE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MENINGOENCEPHALITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANTHRAX; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; CENTRAL NERVOUS SYSTEM INFECTIONS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; HUMANS; MENINGITIS;

EID: 0037386912     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.4.483     Document Type: Review

References (34)

1. Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA. Inhalation anthrax: epidemiology, diagnosis and management. Chest. 1999;116:1369-1376.
2. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biologic warfare agents. JAMA. 1997;278:399-411.
3. Albrink WS, Goodlow RJ. Experimental inhalation anthrax in the chimpanzees. Am J Pathol. 1959;35:1055-1065.
4. Health Aspects of Chemical and Biologic Weapons: Report of WHO Group of Consultants. Geneva, Switzerland: World Health Organization; 1970:99.
5. Anthrax vaccine. Med Lett Drugs Ther. 1998;40:52-53.
6. Hanna P. Anthrax pathogenesis and host response. Curr Top Microbiol Immunol. 1998;225:13-35.
7. Turnbull CHB, Bohm R, Cosivi O, et al. Guldelines for the Surveillance of Anthrax in Humans and Animals. 3rd ed. Geneva, Switzerland: World Health Organization; 1998:1-110.
8. House SJ. Hemorrhagic meningoencephalitis in anthrax: a report of three cases. J Infect Dis. 1920;27:513-526.
9. Ringertz SH, Holby EA, Jensenius M, et al. Injectional anthrax in a heroin skin-popper. Lancet. 2000;356:1574-1575.
10. Kim HJ, Jun WB, Lee SH, Rho MH. CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. Am J Neuroradiol. 2001;22:1303-1305.
11. Garcia AG, Jimenez RR. Images in clinical medicine: Bacillus anthracis meningitis. New Engl J Med. 1999;341:814.
12. Rangel RA, Gonzalez DA. Bacillus anthracis meningitis. Neurology. 1975;25:525-530.
13. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90:2291-2294.
14. Durst UN, Bartenstein J, Buhlmann H, Wust J, Spiegel MV. Anthrax meningitis. Schweiz Med Wochenschr. 1986;116:1222-1228.
15. Fritz DL, Jaax NK, Lawrence WB, et al. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest. 1995;73:691-702.
16. Zaucha GM, Pitt LM, Estep J, Ivins BE, Friedlander AM. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch Pathol Lab Med. 1998;122:982-992.
17. Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. New Engl J Med. 2001;345:1607-1610.
18. Tasyaran MA, Deniz O, Ertek M, Cetin K. Anthrax meningitis: case report and review. Scand J Infect Dis. 2002;34:66-67.
19. Qi Y, Patra G, Liang X, et al. Utilization of the rpoB gene as a specific chromosomal marker for real time PCR detection of Bacillus anthracis. Appl Environ Microbiol. 2001;67:3720-3727.
20. Kwong KL, Wong SN, So KT. Fatal meningoencephaltis due to Bacillus anthracis. J Paediatr Child Health. 1997;33:539-541.
21. Marsham LA, Hardwidge C, Donaldson PM. Bacillus cereus meningitis complicating cerebrospinal fluid fistula repair and spinal drainage. Br J Neurosurg. 2000; 14:580-582.
22. Dancer SJ, McNair D, Finn P, Kolstot AB. Bacillus cereus cellulitis from contaminated heroin. J Med Microbiol. 2002;51:278-281.
23. Flick-Smith HC, Walker NJ, Gibson P, et al. A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect Immun. 2002;70:1653-1656.
24. Watters JW, Dewar K, Lehoczky J, Boyartchuk V, Dietrich WF. Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to lethal factor. Curr Biol. 2001;11:1503-1511.
25. Shin S, Hur GH, Kim YB, et al. Dehydroepiandrosterone and melatonin prevent Bacillus anthracis lethal toxin-induced TNF production in macrophages. Cell Biol Toxicol. 2000;16:165-174.
26. Kerrison JB, Lounsbury D, Thirkill CE, Lane RG, Schatz MP, Engler RM. Optic neuritis after anthrax vaccination. Ophthalmology. 2002;109:99-104.
27. Greidanus TG, Honl BA. Delayed-type hypersensitivity reaction to anthrax vaccine. Mil Med. 2002;167:74-75.
28. Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis. 2002;8:222-225.
29. Brook I, Elliott TB, Pryor HI II, et al. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int J Antimicrob Agents. 2001;18:559-562.
30. Czyhlarz E. Beitrag zur Lehre von der Milzbraind meningitis. Wein Klin Wochenschr. 1916;29:768-769.
31. Shanahan RH, Griffin JR, von Anersperg AP. Anthrax meningitis: report of a case of internal anthrax with recovery. Am J Clin Pathol. 1947;17:719-722.
32. Lanska DJ. Anthrax meningoencephalitis. Neurology. 2002;59:327-334.
33. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933-944.
34. Keim P, Smith KL, Keys C, Takahashi H, Kurata T, Kaufmann A. Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan. J Clin Microbiol. 2001;39:4566-4567.